Orexins mitigate obesity‐associated dysfunctions in mice
Obesity · 2024
DOI: 10.1002/oby.24120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2024. Verfasst von Anne Blais und 11 weiteren Autor:innen. Beteiligte Einrichtung: UMR-PNCA, Université Paris-Saclay, AgroParisTech, Palaiseau, France. Hauptthemen laut MEDLINE: Orexins, Obesity, Mice, Inbred C57BL, Diet, High-Fat. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National League Against Cancer, French National Cancer Institute, Ligue Contre le Cancer.
Abstract (Originalsprache)
Objective
Obesity is a chronic disease that affects more than 400 million adults with severe comorbidities. The search for new treatments to reduce its negative consequences is necessary. Orexins are hypothalamic neuropeptides involved in various physiological processes related to obesity. The aim of this study was to investigate the consequences of chronic orexin‐A treatment in mouse models.
Methods
Female wild‐type C57BL/6 mice that were obesity‐prone or obesity‐resistant and mice that were deficient for orexin receptors were fed with a high‐fat diet. Glucose tolerance, indirect calorimetry, expression of brain neuropeptides and receptors, microglial activation, and microbiota were determined to evaluate the role of orexins on metabolic flexibility.
Results
Orexin‐A reduces weight gain in obesity‐prone mice. This reduction is associated with a decrease in body fat, food intake, steatosis, and insulin resistance, as well as alterations of intestinal microbiota composition. A decreased expression of orexin receptors and neuropeptides involved in food intake was also observed in the hypothalamus.
Conclusions
Our data support the notion that orexin receptor signaling is involved in different aspects of energy metabolism and can mitigate several dysfunctions associated with obesity, suggesting that orexin receptors can represent new targets for obesity treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UMR-PNCA, Université Paris-Saclay, AgroParisTech, Palaiseau, France.
- INSERM UMR1149/Inflammation Research Center (CRI), Université Paris Cité, Paris, France.
ORCID-Profile: Anne Blais
Förderung
- National League Against Cancer
- French National Cancer Institute
- Ligue Contre le Cancer
Zitieren
APA
Blais, A., Denis, I., Andriamihaja, M., Gratio, V., Champeil-Potokar, G., Laouirem, S., Chassac, A., Couvelard, A., Paradis, V., Voisin, T., Davila, A. M., & Couvineau, A. (2024). Orexins mitigate obesity‐associated dysfunctions in mice. Obesity. https://doi.org/10.1002/oby.24120
Vancouver
Blais A, Denis I, Andriamihaja M, Gratio V, Champeil-Potokar G, Laouirem S, et al. Orexins mitigate obesity‐associated dysfunctions in mice. Obesity. 2024. doi:10.1002/oby.24120
BibTeX
@article{Blais2024,
author = {Blais, Anne and Denis, Isabelle and Andriamihaja, Mireille and Gratio, Valérie and Champeil-Potokar, Gaelle and Laouirem, Samira and Chassac, Anais and Couvelard, Anne and Paradis, Valérie and Voisin, Thierry and Davila, Anne-Marie and Couvineau, Alain},
title = {Orexins mitigate obesity‐associated dysfunctions in mice},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24120}
}
EUVIMED